My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 335

    1.

    Frequency of major complications of aspirin, warfarin, and intravenous heparin for secondary stroke prevention. A population-based study.

    Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO.

    Ann Intern Med. 1999 Jan 5;130(1):14-22.PMID: 9890845 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis.

    Hart RG, Benavente O, McBride R, Pearce LA.

    Ann Intern Med. 1999 Oct 5;131(7):492-501.PMID: 10507957 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.

    De Schryver EL, Algra A, van Gijn J.

    Cochrane Database Syst Rev. 2003;(1):CD001820. Review. Update in: Cochrane Database Syst Rev. 2006;(2):CD001820. PMID: 12535415 [PubMed - indexed for MEDLINE]Related articles

    4.

    Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice.

    Caro JJ, Flegel KM, Orejuela ME, Kelley HE, Speckman JL, Migliaccio-Walle K.

    CMAJ. 1999 Sep 7;161(5):493-7. Erratum in: CMAJ 2000 Apr 4;162(7):973. PMID: 10497604 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin.

    Algra A, de Schryver EL, van Gijn J, Kappelle LJ, Koudstaal PJ.

    Cochrane Database Syst Rev. 2001;(4):CD001342. Review. Update in: Cochrane Database Syst Rev. 2006;3:CD001342. PMID: 11687110 [PubMed - indexed for MEDLINE]Related articles

    6.

    Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.

    Flaker GC, Gruber M, Connolly SJ, Goldman S, Chaparro S, Vahanian A, Halinen MO, Horrow J, Halperin JL; SPORTIF Investigators.

    Am Heart J. 2006 Nov;152(5):967-73.PMID: 17070169 [PubMed - indexed for MEDLINE]Related articles

    7.

    Outcomes among valvular heart disease patients experiencing ischemic stroke or transient ischemic attack in Olmsted County, Minnesota.

    Petty GW, Khandheria BK, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO.

    Mayo Clin Proc. 2005 Aug;80(8):1001-8.PMID: 16092578 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Department of Veterans Affairs Cooperative Studies Program Clinical Trial comparing combined warfarin and aspirin with aspirin alone in survivors of acute myocardial infarction: primary results of the CHAMP study.

    Fiore LD, Ezekowitz MD, Brophy MT, Lu D, Sacco J, Peduzzi P; Combination Hemotherapy and Mortality Prevention (CHAMP) Study Group.

    Circulation. 2002 Feb 5;105(5):557-63.PMID: 11827919 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Balancing the risks of stroke and upper gastrointestinal tract bleeding in older patients with atrial fibrillation.

    Man-Son-Hing M, Laupacis A.

    Arch Intern Med. 2002 Mar 11;162(5):541-50.PMID: 11871922 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Medical treatment for stroke prevention.

    Matchar DB, McCrory DC, Barnett HJ, Feussner JR.

    Ann Intern Med. 1994 Jul 1;121(1):41-53. Erratum in: Ann Intern Med 1994 Sep 15;121(6):470. Ann Intern Med 1995 Jun 1;122(11):885. PMID: 7880225 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke.

    Mohr JP, Thompson JL, Lazar RM, Levin B, Sacco RL, Furie KL, Kistler JP, Albers GW, Pettigrew LC, Adams HP Jr, Jackson CM, Pullicino P; Warfarin-Aspirin Recurrent Stroke Study Group.

    N Engl J Med. 2001 Nov 15;345(20):1444-51.PMID: 11794192 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation : a multicenter, prospective, randomized trial. Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperative Study Group.

    Yamaguchi T.

    Stroke. 2000 Apr;31(4):817-21.PMID: 10753981 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Major bleeding in hemodialysis patients.

    Holden RM, Harman GJ, Wang M, Holland D, Day AG.

    Clin J Am Soc Nephrol. 2008 Jan;3(1):105-10. Epub 2007 Nov 14.PMID: 18003768 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Fecal hemoglobin excretion in elderly patients with atrial fibrillation: combined aspirin and low-dose warfarin vs conventional warfarin therapy.

    Blackshear JL, Baker VS, Holland A, Litin SC, Ahlquist DA, Hart RG, Ellefson R, Koehler J.

    Arch Intern Med. 1996 Mar 25;156(6):658-60.PMID: 8629878 [PubMed - indexed for MEDLINE]Related articles

    15.

    Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?

    Go AS, Hylek EM, Chang Y, Phillips KA, Henault LE, Capra AM, Jensvold NG, Selby JV, Singer DE.

    JAMA. 2003 Nov 26;290(20):2685-92.PMID: 14645310 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Secondary stroke prevention with ximelagatran versus warfarin in patients with atrial fibrillation: pooled analysis of SPORTIF III and V clinical trials.

    Akins PT, Feldman HA, Zoble RG, Newman D, Spitzer SG, Diener HC, Albers GW.

    Stroke. 2007 Mar;38(3):874-80. Epub 2007 Jan 25.PMID: 17255547 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators.

    Hart RG, Pearce LA, McBride R, Rothbart RM, Asinger RW.

    Stroke. 1999 Jun;30(6):1223-9.PMID: 10356104 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Treatment for the secondary prevention of stroke in older patients: the influence of dementia status.

    Moroney JT, Tseng CL, Paik MC, Mohr JP, Desmond DW.

    J Am Geriatr Soc. 1999 Jul;47(7):824-9.PMID: 10404926 [PubMed - indexed for MEDLINE]Related articles

    19.

    WITHDRAWN: Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.

    Segal JB, McNamara RL, Miller MR, Powe NR, Goodman SN, Robinson KA, Bass EB.

    Cochrane Database Syst Rev. 2007 Jul 18;(3):CD001938. Review.PMID: 17636690 [PubMed - indexed for MEDLINE]Related articles

    20.

    Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.

    Segal JB, McNamara RL, Miller MR, Powe NR, Goodman SN, Robinson KA, Bass EB.

    Cochrane Database Syst Rev. 2001;(1):CD001938. Review. Update in: Cochrane Database Syst Rev. 2006;(3):CD001938. PMID: 11279741 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity